CSIMarket Company Name, Ticker, Suppliers, else..
 
Microbot Medical Inc   (NASDAQ: MBOT)
 
Price: $1.4600 $-0.04 -2.667%
Day's High: $1.5 Week Perf: 0.00
Day's Low: $ 1.45 30 Day Perf: -24.74 %
Volume (M): 288,002 52 Wk High: $ 4.25
Volume (M$): $ 0 52 Wk Avg: $2.18
Open: $1.49 52 Wk Low: $1.44



 Market Capitalization (Millions $) 98
 Shares Outstanding (Millions) 67
 Employees 43
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -16
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Microbot Medical Inc is a medical device company that specializes in the development and commercialization of innovative robotic technologies designed to improve the minimally invasive surgery experience. The company focuses on the development of robotic systems for various applications, including urology, gynecology, and gastrointestinal procedures. Their devices aim to assist surgeons with precise and controlled movements, ultimately enhancing the effectiveness of surgical procedures while reducing invasiveness and improving patient outcomes.


   Company Address: 175 Derby St. Hingham 2043 MA
   Company Phone Number: 875-3605   Stock Exchange / Ticker: NASDAQ MBOT


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
IRTC   -2.27%    
PAVM   -9.42%    
SNWV   -12.17%    
VYCO      0% 
• View Complete Report
   



Partnership

Microbot Medical Gears Up for LIBERTY™ Launch with Strategic U.S. Logistics Partnership,

Published Tue, Oct 14 2025 1:43 PM UTC

Microbot Medical Partners with U.S.-Based Logistics Provider to Advance Commercial Launch of LIBERTY Endovascular Robotic System Microbot Medical, a forward-thinking medical technology company, has announced a strategic partnership with a U.S.-based logistics provider to support the impending commercial launch of its LIBERTY™ endovascular robotic system. This collaboration...
Management Changes

Microbot Medical Hopes for Turnaround with New Sales Executive Amid Financial Losses,

Published Tue, Mar 4 2025 1:30 PM UTC

Microbot Medical Appoints New Sales Leader Amidst Financial StrugglesIn a bid to bolster its commercial presence, Microbot Medical has announced the appointment of Paul Mullen as the new leader for its U.S. sales activities focusing on the LIBERTY Endovascular Robotic System. Mullen joins the company with a wealth of experience from his most recent role as Director of Sales ...
Shares

Microbot Medical Secures $8.6 Million: A Strategic Step Towards Growth in the Medical Tech Landscape,

Published Wed, Jan 8 2025 1:00 PM UTC

Microbot Medical’s Strategic Funding Initiative: A Positive Step Forward Amidst Market ChallengesIn a pivotal moment for Microbot Medical Inc. (NASDAQ: MBOT), the company recently announced a significant registered direct offering amounting to $8.6 million. This offering is crucial for the company as it navigates the competitive landscape of the medical technology sector. ...
Shares

Microbot Medicals Bold Financial Move: $8.6M Raise Fuels Innovation and Market Confidence,

Published Fri, Jan 10 2025 3:26 PM UTC

Microbot Medical Inc. (Nasdaq: MBOT), a company at the forefront of advanced robotic medical technologies, has recently made a significant stride in capital raising by closing an $8.6 million registered direct offering. This financial maneuver, announced on January 10, 2025, demonstrates the company s proactive approach to fueling its growth and expanding its innovative prod...
Shares

Microbot Medicals Strategic Offering: A Testimony to Growth Prospects

Published Mon, Jan 6 2025 1:01 PM UTC

In a move indicative of its ambitions within the dynamic landscape of healthcare technology, Microbot Medical Inc. has announced a registered direct offering amounting to $7 million. This initiative, which comes just days into 2025, involves the purchase and sale of 4,000,002 shares of the company s common stock at a price of $1.75 per share. Such undertakings, governed by t...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 283.41
Price to Sales (Expected) -
Price to Book 1.42
PEG (TTM) -

Financial Strength Current
Quick Ratio 34.1
Working Capital Ratio 35.08
Leverage Ratio (MRQ) 0.06
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.23 $
Revenues (TTM) 0.01 $
Cash Flow (TTM) -
Cash 1.97 $
Book Value 1.03 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 8,047
Net Income per Employee (TTM) -379,977
Receivable Turnover Ratio (TTM) 4.93
Inventory Turnover Ratio (TTM) 0.69
Asset Turnover Ratio (TTM) 0

Profitability Ratios Current
Gross Margin (MRQ) -266.8 %
Operating Margin (MRQ) -2567.63 %
Net Margin (MRQ) -2334.85 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Microbot Medical Inc's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.